Join to view full profile
Lenox Hill hospital130 East 77th StreetNew York, NY 10075
Dr. Alkabie is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Samir Alkabie is a neurologist based in New York, NY, specializing in neuroimmunology. He completed his neurology residency at SUNY Downstate and pursued advanced fellowship training in multiple sclerosis and autoimmune neurology at Baylor College of Medicine and Western University. He is widely published and committed to translating research advances into better care for his patients.
Education & Training
Western University, London, ONMD, Autoimmune Neurology, 2022 - 2023- Western University, London, ONMD, Multiple Sclerosis, 2021 - 2022
Baylor College of MedicineFellowship, Neuroimmunology & Multiple Sclerosis, 2020 - 2021
SUNY Downstate Health Sciences UniversityResidency, Neurology, 2016 - 2020
Saba University School of MedicineClass of 2016
Certifications & Licensure
NY State Medical License 2020 - 2028
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- Characteristics of myelin oligodendrocyte glycoprotein antibody-associated meningoencephalitis.Aisha Elfasi, Samir Alkabie, Elsa Rodriguez, Mayra Montalvo, Rhaisa Castrodad-Molina
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2026-03-26 - Complement Inhibition for Acute Neuromyelitis Optica Spectrum Disorder Attacks: Insights From an International Case Series.Paulus S Rommer, Wei Jiang, Jan P Nolte, Takahisa Mikami, Jerome De Seze
Neurology(R) Neuroimmunology & Neuroinflammation. 2026-03-01 - Clinico-pathological correlation in unilateral cortical encephalitis treated with tocilizumab after first-line treatment failure.Samir Alkabie, Samer Ali, Saeed Asiry, Ana M Franceschi, Derek Chong
Journal of Neuroimmunology. 2025-12-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
